OxThera AB
556681-5667ActiveDeveloping novel biotherapies for rare kidney diseases like Primary Hyperoxaluria.
Oversikt
- 0
- Ansatte
- ≤1t SEK
- Omsetning
- 2005
- Grunnlagt
Nøkkelbeslutningstakere
Jonas Brambeck
Deputy Director of the Board
John Goldie
Chairman
Mats-Olof Wallin
Chief Financial Officer
Elisabeth Lindner
Chief Operating Officer
Beskrivelse
OxThera AB is a privately-held biopharmaceutical company dedicated to developing novel treatment options for rare kidney diseases, primarily Primary Hyperoxaluria (PH). Their core mission is to improve the quality of life and extend the life expectancy of patients suffering from this devastating ult...
Tagger
Nøkkelord
Teknologier i bruk
Bedriftsinformasjon
- Bransje
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE556681566701
Beslutningstakere
4 kontakter i FunnelfeedrJonas Brambeck
Deputy Director of the Board
John Goldie
Chairman
Mats-Olof Wallin
Chief Financial Officer
Elisabeth Lindner
Chief Operating Officer
Lignende bedrifter
20 lignende bedrifter i FunnelfeedrULTRAGENYX EUROPE GMBH
1–4 ansatteAdvancing transformative medicines for rare and ultra-rare genetic diseases globally.
BioGaia Pharma AB
0 ansatteDeveloping and out-licensing novel biotherapeutic platforms from microbiome research.
Sixera Pharma AB
1–4 ansatteSmall biotech developing first treatment for rare Netherton syndrome.
Calliditas Therapeutics AB
20–49 ansattePioneering novel treatments for rare renal and hepatic diseases globally.
BridgeBio International GmbH
1–4 ansatteDeveloping transformative medicines for rare genetic conditions quickly.
Utforsk mer
Spørsmål om OxThera AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo